California Transplant Services Inc is located in Carlsbad, CA. The organization was established in 2005. According to its NTEE Classification (E65) the organization is classified as: Organ & Tissue Banks, under the broad grouping of Health Care and related organizations. As of 12/2021, California Transplant Services Inc employed 3 individuals. This organization is an independent organization and not affiliated with a larger national or regional group of organizations. California Transplant Services Inc is a 501(c)(3) and as such, is described as a "Charitable or Religous organization or a private foundation" by the IRS.
For the year ending 12/2021, California Transplant Services Inc generated $1.3m in total revenue. This represents a relatively dramatic decline in revenue. Over the past 7 years, the organization has seen revenues fall by an average of (8.3%) each year. All expenses for the organization totaled $1.5m during the year ending 12/2021. As we would expect to see with falling revenues, expenses have declined by (4.6%) per year over the past 7 years. You can explore the organizations financials more deeply in the financial statements section below.
Form
990
Mission & Program ActivityExcerpts From the 990 Filing
TAX YEAR
2021
Describe the Organization's Mission:
Part 3 - Line 1
THE MISSION OF CTS IS TO PROVIDE PROGRAM SERVICES AS A NON-PROFIT EYE AND TISSUE BANK, TO PROVIDE EDUCATION AND IN-SERVICE TRAINING TO MEDICAL PROFESSIONALS, AND COMMUNITY EDUCATION REGARDING EYE AND TISSUE DONATION. TO PROVIDE TISSUE PRESERVATION & CRYOGENIC STORAGE OF AUTOLOGOUS TISSUE FOR LIVING PERSONS DUE TO TRAUMATIC HEAD INJURY OR OTHER ILLNESS INVOLVING SWELLING OF THE BRAIN REQUIRING REMOVAL AND STORAGE OF SKULL BONE, AND TO PROVIDE LONG-TERM STORAGE OF BANKED BONE.
Describe the Organization's Program Activity:
Part 3 - Line 4a
100% OF PROGRAM SERVICE REVENUE FOR 2021 WAS RECEIVED FROM FEES FOR SERVICES RELATED TO EYE AND TISSUE BANKING ACTIVITIES. CTS DISTRIBUTES OCULAR TISSUE FOR CORNEA AND OTHER TYPES OF SIGHT RESTORATIVE SURGERIES. OCULAR TISSUE CTS DISTRIBUTES IS RECOVERED AND PROCESSED BY EYE BANKS THAT ARE REGISTERED WITH THE FDA & MEMBERS OF THE EYE BANK ASSOCIATION OF AMERICA. CTS ALSO DISTRIBUTES ALLOGRAFT TISSUE FOR RECONSTRUCTIVE SURGERY. ALLOGRAFT TISSUE DISTRIBUTED BY CTS IS RECOVERED AND PROCESSED BY TISSUE BANKS THAT ARE ACCREDITED MEMBERS OF THE AMERICAN ASSOCIATION OF TISSUE BANKS, AND REGISTERED WITH THE FDA. CTS IS A NATIONAL REPOSITORY OF AUTOLOGOUS CRANIAL BONE FLAPS RECOVERED FROM LIVING PATIENTS DURING MEDICAL AND TRAUMATIC SURICAL PROCEDURES FOR REIMPLANTATION AT A LATER TIME. CTS PROVIDES HOSPITAL IN-SERVICES, HOSPITAL STAFF TRAINING, DOCUMENTATION, CRYOGENIC STORAGE, AND INTER-FACILITY TISSUE ESCORT SERVICES IN VALIDATED CONTAINERS FOLLOWING PROCEDURES MANDAED BY THE FDA. CTS IS REGISTERED WITH, AND SUBJECT TO THE REGULATORY AUTHORITY OF THE US FOOD AND DRUG ADMINISTRATION FOR THE DISTRIBUTION AND STORAGE OF HUMAN ALLOGRAFT AND AUTOLOGOUS TISSUE. CTS IS LICENSED AS A TISSUE BANK BY THE STATE OF CALIFORNIA DEPARTMENT OF HEALTH, IS A MEMBER OF THE EBAA AND IS AN ACCREDITED INSTITUTIONAL MEMBER OF THE AATB.
Name (title) | Role | Hours | Compensation |
---|---|---|---|
Marc Pablo Vice Pres & Doo | OfficerTrustee | 60 | $435,655 |
Daryl Lirman President & CEO | OfficerTrustee | 60 | $435,619 |
Susan Debruhl Director | Trustee | 1 | $0 |
Christie Horn JD Director | Trustee | 1 | $0 |
Statement of Revenue | |
---|---|
Federated campaigns | $0 |
Membership dues | $0 |
Fundraising events | $0 |
Related organizations | $0 |
Government grants | $0 |
All other contributions, gifts, grants, and similar amounts not included above | $26 |
Noncash contributions included in lines 1a–1f | $0 |
Total Revenue from Contributions, Gifts, Grants & Similar | $26 |
Total Program Service Revenue | $1,824,601 |
Investment income | $244 |
Tax Exempt Bond Proceeds | $0 |
Royalties | $0 |
Net Rental Income | $0 |
Net Gain/Loss on Asset Sales | -$548,620 |
Net Income from Fundraising Events | $0 |
Net Income from Gaming Activities | $0 |
Net Income from Sales of Inventory | $0 |
Miscellaneous Revenue | $0 |
Total Revenue | $1,276,251 |
Statement of Expenses | |
---|---|
Grants and other assistance to domestic organizations and domestic governments. | $0 |
Grants and other assistance to domestic individuals. | $0 |
Grants and other assistance to Foreign Orgs/Individuals | $0 |
Benefits paid to or for members | $0 |
Compensation of current officers, directors, key employees. | $685,597 |
Compensation of current officers, directors, key employees. | $283,159 |
Compensation to disqualified persons | $0 |
Other salaries and wages | $50,724 |
Pension plan accruals and contributions | $0 |
Other employee benefits | $43,987 |
Payroll taxes | $28,344 |
Fees for services: Management | $0 |
Fees for services: Legal | $0 |
Fees for services: Accounting | $25,094 |
Fees for services: Lobbying | $0 |
Fees for services: Fundraising | $0 |
Fees for services: Investment Management | $0 |
Fees for services: Other | $0 |
Advertising and promotion | $0 |
Office expenses | $4,424 |
Information technology | $0 |
Royalties | $0 |
Occupancy | $0 |
Travel | $5,893 |
Payments of travel or entertainment expenses for any federal, state, or local public officials | $0 |
Conferences, conventions, and meetings | $0 |
Interest | $0 |
Payments to affiliates | $0 |
Depreciation, depletion, and amortization | $168,815 |
Insurance | $71,238 |
All other expenses | $61,772 |
Total functional expenses | $1,464,228 |
Balance Sheet | |
---|---|
Cash—non-interest-bearing | $2,730,181 |
Savings and temporary cash investments | $3,551,064 |
Pledges and grants receivable | $0 |
Accounts receivable, net | $206,390 |
Loans from Officers, Directors, or Controlling Persons | $0 |
Loans from Disqualified Persons | $0 |
Notes and loans receivable | $0 |
Inventories for sale or use | $0 |
Prepaid expenses and deferred charges | $0 |
Net Land, buildings, and equipment | $2,946,976 |
Investments—publicly traded securities | $0 |
Investments—other securities | $10,000 |
Investments—program-related | $0 |
Intangible assets | $0 |
Other assets | $0 |
Total assets | $9,444,611 |
Accounts payable and accrued expenses | $10,818 |
Grants payable | $0 |
Deferred revenue | $0 |
Tax-exempt bond liabilities | $0 |
Escrow or custodial account liability | $0 |
Loans and other payables to any current Officer, Director, or Controlling Person | $0 |
Secured mortgages and notes payable | $0 |
Unsecured mortgages and notes payable | $0 |
Other liabilities | $450,059 |
Total liabilities | $460,877 |
Net assets without donor restrictions | $8,983,734 |
Net assets with donor restrictions | $0 |
Capital stock or trust principal, or current funds | $0 |
Paid-in or capital surplus, or land, building, or equipment fund | $0 |
Retained earnings, endowment, accumulated income, or other funds | $0 |
Total liabilities and net assets/fund balances | $9,444,611 |
Organization Name | Assets | Revenue |
---|---|---|
Lions Visiongift Portland, OR | $15,835,054 | $13,517,757 |
Hawaii Organ Procurement Organization Honolulu, HI | $5,561,429 | $7,312,239 |
San Diego Eye Bank San Diego, CA | $4,075,237 | $6,613,986 |
United Tissue Network Inc Phoenix, AZ | $3,493,273 | $3,265,712 |
California Transplant Services Inc Carlsbad, CA | $9,444,611 | $1,276,251 |
Donate Life Northwest Portland, OR | $1,151,515 | $905,523 |
Donate Life California West Sacramento, CA | $2,737,595 | $731,883 |
Simon Keith Foundation Las Vegas, NV | $189,974 | $295,668 |
J J S Legacy Bakersfield, CA | $763,720 | $359,813 |
Armenian Bone Marrow Donor Registry Corp Glendale, CA | $276,525 | $275,607 |
Transplant Community Alliance Inc Phoenix, AZ | $185,342 | $209,971 |
Summit For Stem Cell Foundation Encinitas, CA | $280,936 | $0 |